American society of clinical oncology statement: Human papillomavirus vaccination for cancer prevention

Howard H. Bailey, Linus T. Chuang, Nefertiti C. DuPont, Cathy Eng, Lewis E. Foxhall, Janette K. Merrill, Dana S. Wollins, Charles Blanke

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to savemillions of lives through cancer prevention. As themain providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.

Original languageEnglish (US)
Pages (from-to)1803-1812
Number of pages10
JournalJournal of Clinical Oncology
Volume34
Issue number15
DOIs
StatePublished - May 20 2016

Fingerprint

Medical Oncology
Vaccination
Neoplasms
Hope
Aptitude
Vaccines

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

American society of clinical oncology statement : Human papillomavirus vaccination for cancer prevention. / Bailey, Howard H.; Chuang, Linus T.; DuPont, Nefertiti C.; Eng, Cathy; Foxhall, Lewis E.; Merrill, Janette K.; Wollins, Dana S.; Blanke, Charles.

In: Journal of Clinical Oncology, Vol. 34, No. 15, 20.05.2016, p. 1803-1812.

Research output: Contribution to journalArticle

Bailey, HH, Chuang, LT, DuPont, NC, Eng, C, Foxhall, LE, Merrill, JK, Wollins, DS & Blanke, C 2016, 'American society of clinical oncology statement: Human papillomavirus vaccination for cancer prevention', Journal of Clinical Oncology, vol. 34, no. 15, pp. 1803-1812. https://doi.org/10.1200/JCO.2016.67.2014
Bailey, Howard H. ; Chuang, Linus T. ; DuPont, Nefertiti C. ; Eng, Cathy ; Foxhall, Lewis E. ; Merrill, Janette K. ; Wollins, Dana S. ; Blanke, Charles. / American society of clinical oncology statement : Human papillomavirus vaccination for cancer prevention. In: Journal of Clinical Oncology. 2016 ; Vol. 34, No. 15. pp. 1803-1812.
@article{e5dc6cf414ee40ab80c56705106b3207,
title = "American society of clinical oncology statement: Human papillomavirus vaccination for cancer prevention",
abstract = "American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to savemillions of lives through cancer prevention. As themain providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.",
author = "Bailey, {Howard H.} and Chuang, {Linus T.} and DuPont, {Nefertiti C.} and Cathy Eng and Foxhall, {Lewis E.} and Merrill, {Janette K.} and Wollins, {Dana S.} and Charles Blanke",
year = "2016",
month = "5",
day = "20",
doi = "10.1200/JCO.2016.67.2014",
language = "English (US)",
volume = "34",
pages = "1803--1812",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "15",

}

TY - JOUR

T1 - American society of clinical oncology statement

T2 - Human papillomavirus vaccination for cancer prevention

AU - Bailey, Howard H.

AU - Chuang, Linus T.

AU - DuPont, Nefertiti C.

AU - Eng, Cathy

AU - Foxhall, Lewis E.

AU - Merrill, Janette K.

AU - Wollins, Dana S.

AU - Blanke, Charles

PY - 2016/5/20

Y1 - 2016/5/20

N2 - American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to savemillions of lives through cancer prevention. As themain providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.

AB - American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to savemillions of lives through cancer prevention. As themain providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.

UR - http://www.scopus.com/inward/record.url?scp=84969504946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969504946&partnerID=8YFLogxK

U2 - 10.1200/JCO.2016.67.2014

DO - 10.1200/JCO.2016.67.2014

M3 - Article

C2 - 27069078

AN - SCOPUS:84969504946

VL - 34

SP - 1803

EP - 1812

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 15

ER -